https://doctransparency.com/doctor/fl/stuart/rabih-kashouty-1487946539
Medicare Enrolled

Dr. Rabih Kashouty, MD

Clinical Neuropsychologist · Stuart, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1026 SE FEDERAL HIGHWAY, Stuart, FL 34994
7722102447
In practice since 2011 (14 years)
NPI: 1487946539 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kashouty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kashouty? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kashouty

Dr. Rabih Kashouty is a clinical neuropsychologist in Stuart, FL, with 14 years in practice. Based on federal Medicare data, Dr. Kashouty performed 29,442 Medicare services across 881 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kashouty received a total of $44,676 from 77 pharmaceutical and/or device companies across 1169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical neuropsychologist. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kashouty is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 1% volume in FL$ $44,676 industry payments

Medicare Practice Summary

Medicare Utilization ↗
29,442
Medicare services
Top 1% in FL for clinical neuropsychologist
881
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,103 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit24,300$5$21
Injection, rimabotulinumtoxinb, 100 units2,670$10$42
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour753$16$78
Needle measurement of electrical activity in arm or leg muscles, complete study460$78$351
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less211$50$259
Injection of drug or substance into vein166$29$143
Nerve conduction, 9-10 studies160$162$830
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle143$60$284
Office visit, established patient (30-39 min)141$91$397
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box80$171$2,272
Injection of additional new drug or substance into vein66$12$59
Nerve conduction, 13 or more studies45$224$1,101
Injection of chemical for paralysis of nerve muscles on side of face32$162$2,326
New patient office visit (45-59 min)32$121$606
Complete ultrasound scan of joint31$44$280
Nerve conduction, 11-12 studies31$195$952
Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity30$124$678
Ultrasonic guidance for needle placement30$47$209
Injection of chemical for paralysis of salivary glands on both sides of mouth27$107$475
Comprehensive ultrasound scan of entire length of nerves in extremity20$59$203
Nerve conduction, 7-8 studies14$132$695
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.3% high complexity
93.6% medium
3.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$44,676
Total received (2018-2024)
Avg $6,382/year across 7 years
Top 50% in FL for clinical neuropsychologist
77
Companies
1,169
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26,120 (58.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,556 (41.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,132
2023
$2,236
2022
$3,079
2021
$2,555
2020
$3,586
2019
$13,624
2018
$17,465

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$25,553
ABBVIE INC.
$1,514
Biogen, Inc.
$1,372
Merz North America, Inc.
$1,166
UCB, Inc.
$978
Allergan, Inc.
$919
ACADIA Pharmaceuticals Inc
$859
Sunovion Pharmaceuticals Inc.
$829
PFIZER INC.
$550
GENZYME CORPORATION
$549
Teva Pharmaceuticals USA, Inc.
$535
US WorldMeds, LLC
$521
Supernus Pharmaceuticals, Inc.
$460
ARGENX US, INC.
$442
Allergan Inc.
$440
Zyla Life Sciences
$431
Kyowa Kirin, Inc.
$370
Galderma Laboratories, L.P.
$353
CSL Behring
$318
EISAI INC.
$297
AQUESTIVE THERAPEUTICS, INC.
$293
AbbVie Inc.
$289
Egalet US Inc
$267
SK Life Science, Inc.
$262
Lundbeck LLC
$225
Neurelis, Inc.
$210
Bausch Health US, LLC
$203
Amgen Inc.
$192
LivaNova USA, Inc.
$189
Janssen Pharmaceuticals, Inc
$188
Lilly USA, LLC
$186
Zyla Life Sciences, Inc.
$182
EMD Serono, Inc.
$175
Celgene Corporation
$161
JAZZ PHARMACEUTICALS INC.
$160
MITSUBISHI TANABE PHARMA AMERICA, INC.
$158
Greenwich Biosciences, Inc.
$155
Biohaven Pharmaceutical Holding Company Ltd.
$141
Novartis Pharmaceuticals Corporation
$140
Adamas Pharmaceuticals, Inc.
$136
Neurocrine Biosciences, Inc.
$134
Eisai Inc.
$128
Amneal Pharmaceuticals LLC
$124
Avanir Pharmaceuticals, Inc.
$123
MERZ NORTH AMERICA, INC.
$119
Grifols USA, LLC
$116
MDD US Operations, LLC
$112
Abbott Laboratories
$109
Merz Pharmaceuticals, LLC
$99
REVANCE THERAPEUTICS, INC.
$96
Acorda Therapeutics, Inc
$95
Biohaven Pharmaceuticals, Inc.
$92
E.R. Squibb & Sons, L.L.C.
$85
GE HEALTHCARE
$70
ARBOR PHARMACEUTICALS, INC.
$67
AbbVie, Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$58
Upsher-Smith Laboratories LLC
$54
Horizon Therapeutics plc
$50
Jazz Pharmaceuticals Inc.
$45
GE HealthCare
$42
Alfasigma USA, Inc.
$40
Octapharma USA, Inc.
$39
Avion Pharmaceuticals
$38
Promius Pharma LLC
$36
IDORSIA PHARMACEUTICALS US INC
$34
Microtransponder, Inc.
$33
Sumitomo Pharma America, Inc.
$31
Arbor Pharmaceuticals, Inc.
$30
Aucta Pharmaceuticals, Inc.
$25
Genentech USA, Inc.
$22
InSightec,Inc
$21
SANOFI-AVENTIS U.S. LLC
$20
CATALYST PHARMACEUTICALS, INC.
$15
UPSHER-SMITH LABORATORIES LLC
$14
Almatica Pharma LLC
$13
Mitsubishi Tanabe Pharma America, Inc.
$13
Top 3 companies account for 63.7% of total payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · Briviact · COMIRNATY · DUOPA · Dayvigo · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Exablate · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · Ongentys · PANZYGA · PLEGRIDY · Ponvory · Proclaim Family of SCS IPGs · Proclaim IPG · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Radicava · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · THROMBIN-JMI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZORVOLEX · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in clinical neuropsychologist and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $152 per 100 Medicare services performed
Looking for a clinical neuropsychologist in Stuart?
Compare clinical neuropsychologists in the Stuart area by procedure volume, costs, and industry payment transparency.
Browse clinical neuropsychologists nearby

Geographic Context

Clinical Neuropsychologists within 10 mi
9
Per 100K population
5.6
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kashouty is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and speaking/promotional industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kashouty experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kashouty performed 24,300 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kashouty receive payments from pharmaceutical companies?
Yes. Dr. Kashouty received a total of $44,676 from 77 companies across 1,169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kashouty's costs compare to other clinical neuropsychologists in Stuart?
Dr. Kashouty's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kashouty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →